0001225208-12-016683.txt : 20120726 0001225208-12-016683.hdr.sgml : 20120726 20120726161634 ACCESSION NUMBER: 0001225208-12-016683 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20120720 FILED AS OF DATE: 20120726 DATE AS OF CHANGE: 20120726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elicker John E CENTRAL INDEX KEY: 0001554788 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 12987624 MAIL ADDRESS: STREET 1: BRISTOL-MYERS SQUIBB COMPANY STREET 2: ROUTE 206 & PROVINCELINE ROAD CITY: LAWRENCEVILLE STATE: NJ ZIP: 08543 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 3 1 doc3.xml X0206 3 2012-07-20 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001554788 Elicker John E BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 1 SVP Pub Affairs & Inv Relation Common Stock, $0.10 par value 24675.5000 D Market Share Units 2015-03-01 Common Stock, $0.10 par value 4080.0000 D Market Share Units 2014-03-02 Common Stock, $0.10 par value 2753.0000 D Market Share Units 2016-03-06 Common Stock, $0.10 par value 4172.0000 D Option (right to buy) 17.5100 2019-03-02 Common Stock, $0.10 par value 19723.0000 D Option (right to buy) 22.1400 2018-03-03 Common Stock, $0.10 par value 7377.0000 D Option (right to buy) 27.0100 2017-03-05 Common Stock, $0.10 par value 6615.0000 D Option (right to buy) 28.1100 2014-03-01 Common Stock, $0.10 par value 16875.0000 D Performance Shares 2013-03-31 Common Stock, $0.10 par value 7720.7700 D Performance Shares 2014-03-31 Common Stock, $0.10 par value 3976.9300 D Restricted Stock Units 2017-01-03 Common Stock, $0.10 par value 2852.0000 D Restricted Stock Units 2013-03-03 Common Stock, $0.10 par value 1851.0000 D Restricted Stock Units 2014-05-03 Common Stock, $0.10 par value 3017.0000 D 1,360 market share units will vest on each of March 1, 2013, March 1, 2014 and March 1, 2015. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. 1,376 market share units will vest on March 2, 2013 and 1,377 market share units will vest on March 2, 2014. Twenty-five percent of the market share unit award will vest on each of the first, second, third, and fourth anniversaries of the grant date, starting on March 6, 2013. 9,882 shares are currently exercisable. The remaining 9,841 shares will become exercisable on March 3, 2013. All of the shares are currently exercisable. Consists of 7,145 performance shares and 575.77 performance shares representing dividend equivalents earned under the 2010-2012 Long Term Performance Award. Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. Consists of 3,767 performance shares and 209.93 performance shares representing dividend equivalents earned under the 2011-2013 Long Term Performance Award. Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. 952 restricted stock units will vest on January 3, 2015, and 950 restricted stock units will vest on each of January 3, 2016 and January 3, 2017. Each restricted stock unit converts into one share of common stock upon vesting. These restricted stock units will vest on March 3, 2013. 1,508 restricted stock units will vest on May 3, 2013 and 1,509 restricted stock units will vest on May 3, 2014. Exhibit 24 - Power of Attorney /s/ John E. Elicker 2012-07-26 EX-24 2 elicker_poa.txt Exhibit 24 POWER OF ATTORNEY I, John E. Elicker, Senior Vice President, Public Affairs and Investor Relations, of Bristol-Myers Squibb Company (the "Company"),a corporation duly organized and existing under the laws of the State of Delaware, in the United States of America, and having its principal place of business at 345 Park Avenue, New York, New York, do hereby constitute and appoint each of Sandra Leung, Katherine R. Kelly, and Robert J. Wollin, individually, as my lawful attorney-in-fact and in my name, place and stead to execute and deliver any and all documents relating to insider reporting requirements under Section 16 of the Securities Exchange Act of 1934, with respect to securities issued by the Company, including, without limitation, the execution and filing of all Forms 3, 4 and 5, and to take such other action, as such attorney considers necessary or appropriate, to effectuate such transactions. This Power of Attorney shall remain in full force and effect until I am no longer required to file Forms 3, 4, and 5 with respect to securities issued by the Company, unless earlier revoked. IN WITNESS WHEREOF, I have executed this Power of Attorney on this 23rd day of July, 2012. /s/ John E. Elicker John E. Elicker